Trial intelligence / Profile preview

Fospropofol disodium versus propofol for maintenance of general anesthesia in elderly surgical patients

ChiCTR2300073734Phase 4Recruiting

Sponsor
Hefei BOE Hospital
Start
Jul 2023
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of fospropofol disodium and propofol, sponsored by Hefei BOE Hospital. Primary endpoints: Hemodynamic indexes and Cognitive function. Started Jul 2023; status: recruiting.

02

Drugs

fospropofol disodiumpropofol

Beyond the preview

Go deeper on ChiCTR2300073734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300073734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call